Biopreservation Market Research Report, Analysis and Forecast – (2021 – 2028)

Biopreservation Market Trends Reshaping the Life Sciences Sector 

The biopreservation market is undergoing a profound transformation, fueled by advances in biotechnology, growing demand for cell-based therapies, and the increasing need to preserve biological specimens. This market is expanding rapidly, driven by the convergence of personalized medicine and the need for secure long-term storage of tissues, cells, and organs. For instance, as stem cell banking gains momentum globally, the biopreservation market is becoming essential in maintaining the viability and functionality of these samples over extended periods. 

Across the globe, institutions are investing in high-capacity biopreservation systems to support translational research and therapeutic development. Such expansion is aligned with the ongoing demand for advanced diagnostics, particularly in oncology and neurology. These fields require robust biospecimen storage capabilities, which further reinforces the rising value proposition of the biopreservation market in clinical and research settings. 

Biopreservation Market Growth Driven by Regenerative Medicine and Cellular Therapies 

A key driver of the biopreservation market is the exponential growth of regenerative medicine and cellular therapies. The clinical pipeline for therapies using stem cells, engineered tissues, and immune cells is expanding each year. For example, the number of cell therapy clinical trials has surged over 50% in the last five years, requiring stringent preservation protocols to safeguard cell integrity during storage and transport. This trend has directly influenced the uptake of cryopreservation equipment and reagents, positioning the biopreservation market as a vital enabler of therapeutic innovation. 

In addition, the global shift toward minimally invasive procedures has increased demand for biocompatible preservation solutions. These solutions ensure that biological samples used in treatment or diagnosis remain uncontaminated and effective. Consequently, manufacturers are focusing on improving the safety, sterility, and scalability of their biopreservation products to meet evolving clinical requirements. 

Rising Biobanking Initiatives Fueling the Biopreservation Market 

The proliferation of biobanking initiatives is creating strong tailwinds for the biopreservation market. National and private biobanks are expanding their capacity to store millions of biological samples, including DNA, plasma, serum, and viable cells. As these institutions require reliable long-term storage solutions, the demand for ultra-low temperature freezers, cryogenic vials, and cold chain logistics is accelerating. 

For instance, population-scale genomic studies often involve the collection and preservation of tens of thousands of samples. Such projects require not only physical infrastructure but also high-performing preservation media to maintain sample quality over time. This need has triggered greater investment in temperature-stable preservatives and software-controlled storage systems, pushing the biopreservation market toward smarter, more automated platforms. 

Biopreservation Market Size Grows with Precision Medicine Expansion 

As precision medicine evolves, so does the need for biologically preserved material. The biopreservation market size is expanding alongside the growth of targeted therapies, where individualized treatment plans depend heavily on the analysis of stored biological data. For instance, companion diagnostics often require preserved biopsy specimens, which must retain their molecular integrity from collection to analysis. This has elevated the role of biopreservation in delivering consistent, reproducible clinical outcomes. 

The expansion of pharmaceutical R&D pipelines has also driven the growth of the biopreservation market size. Drug developers increasingly rely on preserved human tissues and cell cultures for high-throughput screening and toxicity studies. This surge in preclinical research activity has fueled demand for next-generation storage solutions capable of maintaining stability over longer cycles. 

 

Biopreservation Market Growth Across North America 

North America represents the most mature and technologically advanced segment of the global biopreservation market. The region accounted for nearly 45% of global revenue in 2024, and Datavagyanik expects this dominance to continue through 2034, driven by robust infrastructure, continuous research funding, and well-established biobanking networks. The United States alone houses over 300 biobanks, which collectively store millions of biospecimens ranging from cord blood to tumor tissues. 

For instance, the growing number of clinical trials involving stem cell and CAR-T therapies is significantly increasing biopreservation demand in the U.S. Moreover, the National Institutes of Health and other government agencies have intensified their support for precision medicine initiatives, which inherently rely on high-quality preserved biological samples. This expansion reinforces the strategic importance of biopreservation systems across academic, pharmaceutical, and contract research organizations. 

Europe’s Strategic Role in the Global Biopreservation Market 

Europe is the second-largest contributor to the global biopreservation market. Countries such as Germany, the UK, and France lead the regional demand due to their investment in public health initiatives and strong pharmaceutical manufacturing base. For instance, Germany has increased its clinical research spending by over 20% since 2020, with a significant portion directed toward genomic and cellular research. 

Additionally, collaborative efforts such as the European Biobanking and BioMolecular Resources Research Infrastructure (BBMRI-ERIC) have scaled up the continent’s storage capacity. As these networks grow, so does the requirement for ultra-low temperature equipment, cryoprotectants, and advanced logistics, directly fueling biopreservation demand. With more than 600 million citizens and strong regulatory frameworks, Europe remains a high-potential market for innovative preservation technologies. 

Biopreservation Market Expanding Rapidly in Asia-Pacific 

The Asia-Pacific region has emerged as the fastest-growing territory in the global biopreservation market. Countries such as China, India, South Korea, and Japan are witnessing increased investment in biotechnology, personalized medicine, and clinical trials. Datavagyanik estimates that the biopreservation market in Asia-Pacific will register a CAGR of over 31% between 2024 and 2034. 

For example, China’s rapid expansion of stem cell therapy research has directly contributed to a rise in biopreservation demand for cryogenic systems and storage media. In India, more than 50 private stem cell banks have been established in the past five years, and demand for pediatric biopreservation services such as cord blood banking is growing at more than 15% annually. These trends indicate a clear regional shift toward adopting advanced biological storage solutions. 

Latin America and Middle East’s Growing Share in Biopreservation Market 

While traditionally underpenetrated, Latin America and the Middle East are beginning to attract attention in the global biopreservation market. In Brazil, increasing public-private partnerships in regenerative medicine are encouraging hospitals and research centers to adopt standardized preservation techniques. Meanwhile, countries like the UAE and Saudi Arabia are making strides in healthcare modernization, contributing to regional growth in biopreservation demand. 

In both regions, the rise in non-communicable diseases such as cancer and diabetes is creating demand for reliable biosample preservation. For instance, precision diagnostics based on preserved blood plasma and biopsy samples are gaining traction, requiring cold chain and biorepository capabilities that feed directly into the regional biopreservation market. 

Market Segmentation: Product-Wise Insights in the Biopreservation Market 

The biopreservation market is broadly segmented into equipment, media, and laboratory information management systems (LIMS). Equipment dominates the segment, contributing over 55% of the total market revenue in 2024. For instance, ultra-low temperature freezers and liquid nitrogen tanks are extensively deployed in both clinical and research environments. Datavagyanik projects this segment to continue leading through the forecast period as the installed base of biopreservation units expands globally. 

Preservation media is another fast-growing category, expected to grow at over 30% annually. Growth in this segment is being driven by the increasing need for customized cryoprotective agents tailored to preserve specific cell types such as stem cells, hepatocytes, or neurons. The use of chemically defined, serum-free media is also becoming more prevalent as biopharma firms aim to reduce variability and contamination risk. 

LIMS, while smaller in market share, is experiencing notable growth due to its role in managing, tracking, and maintaining large volumes of preserved samples. Institutions managing hundreds of thousands of specimens require integrated data systems, and the demand for automated inventory systems has created a niche but expanding space within the biopreservation market. 

Market Segmentation by Application Areas in the Biopreservation Market 

Application-wise, the biopreservation market can be segmented into regenerative medicine, biobanking, drug discovery, and diagnostics. Among these, regenerative medicine is the fastest-growing application, accounting for more than 35% of the total market share in 2024. The increasing use of stem cell-based therapies in neurology, cardiology, and oncology has heightened the biopreservation demand for viable cell storage solutions. 

Biobanking represents the largest segment by volume, contributing over 40% of market demand. For instance, population-scale genomic programs in North America and Europe continue to bank vast volumes of DNA, serum, and whole blood samples. As these samples must remain stable for decades, institutions are investing in high-performance storage solutions and preservation agents. 

In drug discovery, preserved human tissue models and 3D cell cultures are replacing animal testing, leading to new preservation requirements. For example, hepatocyte and renal cell cultures used in ADME-Tox studies require customized short- and long-term biopreservation solutions. Diagnostics is another key segment, particularly in cancer genomics, where frozen biopsies are crucial for molecular testing. 

Pricing Trends and Competitive Landscape in the Biopreservation Market 

Price dynamics in the biopreservation market vary by segment and region. Equipment such as ultra-low temperature freezers typically ranges from USD 8,000 to USD 25,000 per unit, depending on storage capacity and features. Liquid nitrogen storage tanks are generally priced lower, but operational costs can rise with larger-scale usage. Preservation media pricing has been increasing steadily, especially for serum-free and GMP-grade formulations, reflecting higher production costs and regulatory compliance standards. 

Datavagyanik observes that prices in emerging markets are more competitive due to the entry of regional manufacturers offering cost-effective alternatives. However, in developed economies, pricing premiums persist for advanced systems with automation and remote monitoring capabilities. Vendors are increasingly offering bundled packages that include equipment, media, and software to enhance value and customer retention. 

The competitive landscape is marked by innovation in areas such as energy-efficient storage, cloud-based inventory tracking, and AI-assisted condition monitoring. These advancements are enabling companies to command premium prices while also meeting evolving customer expectations in terms of sample security and long-term viability. 

Forecasting Biopreservation Demand Across Segments 

The future outlook for biopreservation demand is highly promising. As new cell and gene therapies receive regulatory approval, healthcare systems will need to scale their preservation infrastructure to accommodate higher throughput. For instance, CAR-T therapies often require the storage of patient-specific cells across multiple process points, significantly increasing storage needs per patient. 

Furthermore, aging populations worldwide are expected to contribute to chronic disease prevalence, which will increase the number of biopsies, plasma samples, and other biological materials collected for long-term analysis. Each of these application areas contributes to growing biopreservation demand. 

Additionally, consumer awareness is playing a role. In markets such as India and Southeast Asia, there is growing demand for private cord blood banking and fertility-related preservation services. This diversification of demand sources is creating new opportunities across service providers and equipment manufacturers alike. 

 

Leading Companies Shaping the Biopreservation Market 

The biopreservation market is dominated by a group of highly competitive and innovation-driven players that collectively account for a significant portion of global market revenues. These companies have successfully leveraged their R&D strength, product diversification, and global distribution networks to capture demand across research, clinical, and commercial applications. 

Thermo Fisher Scientific leads the global biopreservation market, commanding close to 18 percent of the total share. The company’s extensive range of ultra-low temperature freezers, cryogenic storage systems, and preservation reagents is widely adopted in biobanking, pharmaceuticals, and stem cell therapy labs. Key products such as the Forma CryoPlus storage systems and Nalgene cryoware range offer superior temperature control and durability, which has helped the company sustain its leadership position. 

Merck KGaA follows with an estimated 12 percent share in the biopreservation market. The company’s CryoSure cryopreservation media is used across various applications including stem cell banking, tissue storage, and primary cell lines. Merck’s focus on GMP-compliant solutions has made it a trusted partner for advanced therapy medicinal product developers. The company also offers integrated cold storage solutions tailored to meet the demands of long-term sample integrity. 

Chart Industries maintains a strong presence in the market with around 6 percent share. Its cryogenic freezers and large-capacity liquid nitrogen tanks serve industrial biopreservation needs in cell therapy manufacturing hubs. With a focus on high-volume solutions, Chart Industries plays a critical role in supporting temperature-sensitive storage across regenerative medicine and vaccine development programs. 

ThermoGenesis, with a portfolio built around stem cell preservation, holds nearly 6 percent of the global biopreservation market. Its automated cell processing and storage platforms are deployed in cord blood banks and regenerative medicine facilities across multiple continents. The company’s proprietary AXP platform and BioArchive system deliver both scalability and regulatory compliance. 

Becton, Dickinson and Company (BD) is another notable player, with a market share approaching 5 percent. BD offers advanced biopreservation consumables such as cryovials, freezer boxes, and temperature-stable reagents. Its CellVault storage system integrates monitoring and tracking tools designed for sample protection in large biobanks. 

Cryoport has emerged as a leader in cryogenic logistics, covering approximately 4 percent of the biopreservation market. Its Express Shipper range allows for secure and temperature-controlled transport of cellular materials. Cryoport’s logistics services are increasingly adopted by pharmaceutical companies and cell therapy developers for global sample movements. 

Helmer Scientific accounts for nearly 4 percent of market revenues with its lineup of medical-grade refrigeration and ultra-low temperature freezers. The company caters to hospitals, blood banks, and research labs with equipment that ensures accurate temperature management and sample stability. 

Biocision, a specialist in sample preservation and stabilization, commands 3 percent of the biopreservation market. Its range of Snap Freeze platforms and temperature-sensitive gel packs is used in short-term sample preservation in diagnostics and clinical trials. 

Sakura Finetek also contributes 3 percent, driven largely by its advanced tissue processing and storage systems. The company’s tissue preservation platforms are widely deployed in pathology labs and offer a critical bridge between collection and analysis. 

Ilab, a rising player from the Asia-Pacific region, has gained market presence by offering cost-effective and modular biopreservation systems. Its emphasis on region-specific needs and after-sales support has helped it secure around 3 percent of the global biopreservation market, especially in emerging countries. 

 

Product Portfolios Supporting Global Biopreservation Demand 

These market players collectively offer a comprehensive suite of solutions designed to handle increasing biopreservation demand from stem cell therapy, cell-based assays, diagnostics, and population-scale biobanking programs. 

For instance, Thermo Fisher’s high-density CryoPlus storage systems are compatible with automated handling systems, which is crucial for labs processing thousands of samples daily. Merck’s CryoSure media comes in both research-grade and GMP-grade versions, ensuring safety and efficacy for clinical applications. 

Cryoport’s cloud-enabled logistics tracking ensures real-time updates on temperature, location, and vial integrity, addressing a critical pain point in global sample transport. Helmer’s cryogenic platforms are increasingly used in oncology research, where even minor temperature deviations can compromise sample reliability. 

With the introduction of temperature-stable gel technologies, Biocision has provided a much-needed solution for last-mile sample stabilization, especially in regions lacking deep cold infrastructure. 

 

Recent Developments in the Biopreservation Market 

The biopreservation market has witnessed several key developments in 2024 and 2025, shaping the industry’s competitive landscape and innovation direction. 

In February 2025, Merck introduced a new variant of its cryopreservation media designed specifically for genetically modified T-cell therapies. This launch marks a shift toward product personalization in response to specific therapy needs. 

Thermo Fisher launched a next-generation AI-enabled freezer monitoring solution in March 2025. This system uses predictive analytics to prevent temperature excursions, a common cause of sample loss. It is currently being piloted across multiple academic and clinical research centers. 

In April 2025, Chart Industries finalized a partnership with a Southeast Asian biotech cluster to establish a dedicated cryogenic storage facility with over 20,000 liters of liquid nitrogen capacity. This move is aimed at serving the region’s growing regenerative medicine market. 

Cryoport, in May 2025, expanded its logistics infrastructure with the addition of a new facility in the Netherlands, increasing its coverage across European clinical trial sites. The move supports rising biopreservation demand tied to cross-border sample shipping. 

Helmer Scientific, in June 2025, signed a technology collaboration agreement with a Korean diagnostics firm to co-develop ultra-stable cryogenic freezers optimized for molecular testing labs. This partnership aligns with the growing trend toward disease-specific sample preservation. 

 

Key Insights that the Biopreservation Market analysis report presents are:

• Biopreservation Market revenue and demand by countries
• Break-down of the Biopreservation Market in terms of application areas, target customers, and other potential market segments
• Areas that are relatively more potential and are faster growing
• Biopreservation Market competitive scenario, market share analysis
• Biopreservation Market business opportunity analysis

Global and Country-Wise Biopreservation Market Statistics

• Global and Country-Wise Biopreservation Market Size ($Million) and Forecast – (2021-2028)
• Global and Country-Wise Biopreservation Market Trend Analysis
• Global and Country-Wise Biopreservation Market Business Opportunity Assessment